Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Play AI’s “iPhone Moment” in Cloud Computing ETF WCLD
Believe it or not, there was a world before the smart phone, and indeed, before the iPhone. Apple (AAPL) profoundly changed our daily lives with
RiverNorth Managed Duration Municipal Income Fund II (RMMZ) Declares $0.10 Dividend
RiverNorth Managed Duration Municipal Income Fund II said on April 3, 2023 that its board of directors declared a regular monthly dividend of $0.10 per
Amazon plans to trim employee stock awards amid tough economy By Reuters
© Reuters. FILE PHOTO: The logo of Amazon is seen at the company logistics center in Lauwin-Planque, northern France, January 5, 2023. REUTERS/Pascal Rossignol (Reuters)
Unusual Call Option Trade in JD.com (JD) Worth $474.92K
On April 5, 2023 at 10:06:33 ET an unusually large $474.92K block of Call contracts in JD.com (JD) was sold, with a strike price of
Wells Fargo Maintains Acuity Brands (AYI) Overweight Recommendation
Fintel reports that on April 5, 2023, Wells Fargo maintained coverage of Acuity Brands (NYSE:AYI) with a Overweight recommendation. Analyst Price Forecast Suggests 22.46% Upside
Notable Two Hundred Day Moving Average Cross – ICVT
In trading on Wednesday, shares of the iShares Convertible Bond ETF (Symbol: ICVT) crossed below their 200 day moving average of $71.66, changing hands as
AllianceBernstein Global High Income Fund (AWF) Declares $0.07 Dividend
AllianceBernstein Global Hgh Incm Fd said on April 4, 2023 that its board of directors declared a regular monthly dividend of $0.07 per share ($0.79
S&P 500 ends lower as recession fears take center stage By Reuters
© Reuters. FILE PHOTO: Traders work on the trading floor at the New York Stock Exchange (NYSE) in New York City, U.S., March 31, 2023.
Unusual Put Option Trade in GameStop (GME) Worth $349.65K
On April 5, 2023 at 10:03:36 ET an unusually large $349.65K block of Put contracts in GameStop (GME) was bought, with a strike price of
JP Morgan Maintains Relay Therapeutics (RLAY) Overweight Recommendation
On April 5, 2023, JP Morgan maintained coverage of Relay Therapeutics with a Overweight recommendation. Analyst Price Forecast Suggests 103.68% Upside As of March 30,